MoiraLAitkenMD
Pulmonology • Seattle, WAPleural Disease
Professor, Medicine, University of Washington School of Medicine
Are you Dr. Aitken?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
PO Box
# 1959
Seattle, WA 98195Phone+1 206-598-4615Fax+1 206-598-6963
Summary
- Dr. Moira Aitken, MD is a pulmonologist in Seattle, Washington. She is currently licensed to practice medicine in Washington. She is affiliated with UW Medicine/University of Washington Medical Center and is a Professor at University of Washington School of Medicine.
Education & Training
University of Edinburg Medical SchoolClass of 1978, MD
Certifications & Licensure
WA State Medical License 1983 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Long Term Administration of Inhaled Mannitol in Cystic Fibrosis Start of enrollment: 2008 Sep 01
- A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects Start of enrollment: 2014 Sep 01
- Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Qualitative Analysis of Perspectives on Lung Transplant among People with Cystic Fibrosis.Tijana Milinic, Mara R Hobler, Lauren E Bartlett, Eliana Gill, Nora Burdis
Annals of the American Thoracic Society. 2024-07-01 - 1 citations"We'll deal with it as it comes": A Qualitative Analysis of Romantic Partners' Dyadic Coping in Cystic Fibrosis.Nancy Lau, Kathleen J Ramos, Moira L Aitken, Christopher H Goss, Krysta S Barton
Journal of Social and Personal Relationships. 2024-04-01 - Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis.Andrew Hart, Francine Cesar, Leila R Zelnick, Nick O'Connor, Zoie Bailey
Journal of Cystic Fibrosis. 2024-03-01
Press Mentions
- The Association Between Heroin Inhalation and Early Onset EmphysemaJuly 17th, 2020
New Medication Effectively Treats Underlying Cause of Cystic Fibrosis in Some Patients, Study ShowsNovember 3rd, 2011- Who Gets Early Tracheostomy?: Evidence of Unequal Treatment at 185 Academic Medical CentersFebruary 10th, 2016
- Join now to see all
Grant Support
- A Phase IIA Safety And Efficacy Study Of Oral Spi-8811 In Patients With CFNational Center For Research Resources2005
- Safety And Tolerability Study Of Theraclec-Total In Subjects With CFNational Center For Research Resources2004
- Phase IIA Safety And Efficacy Study Of Oral Spi-8811National Center For Research Resources2004
- Oral Multidose CPX In Adult PTS W/ Mild To Severe CFNational Center For Research Resources2000–2002
- Efficacy, &Methodology Study In Atopic PTS W/ AsthmaNational Center For Research Resources2000–2002
- Phase II Trial Of Oral Multidose CPX In Adult Patients W/ Mild To CFNational Center For Research Resources1999–2000
- Multiple Oral Dose Safety, Efficacy, &Methodology Study In AtopicNational Center For Research Resources1999–2000
- Phase I Trial Of CPX In Adults With Mild Cystic FibrosisNational Center For Research Resources1998–2000
- Nontuberculous Mycobacteria In Patients With Cystic FibrosisNational Center For Research Resources1997–2000
- Phase I Trial CPX In Adult Patients With Mild Cystic FibrosisNational Center For Research Resources1998–1999
- Pilot Study--Aav For Gene Transfer And Expression In Rabbit Airway EpitheliumNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Development Toward An In Vivo Model For CF Gene TherapyNational Heart, Lung, And Blood Institute1996–1999
- Cellular Differentiation Of Airway EpitheliumNational Heart, Lung, And Blood Institute1987–1991
